CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $25,980
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-03-15 | EPIC INVESTMENTS, LLC 10% owner | Purchase · Series E Convertible Preferred Stock | +125 | $1,000.00 | $125K | 1,750 |
| 2012-03-14 | NARINE JEENARINE Director | Conversion | +7,621,951 | 63,851,618 | ||
| 2012-03-14 | NARINE JEENARINE Director | Conversion · Series E Convertible Preferred Stock | −187.5 | $1,000.00 | $188K | 1,625 |
| 2012-03-14 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion | +7,621,951 | 63,851,618 | ||
| 2012-03-14 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion · Series E Convertible Preferred Stock | −187.5 | $1,000.00 | $188K | 1,625 |
| 2012-03-14 | POTTI RAM Director | Conversion | +7,621,951 | 63,443,669 | ||
| 2012-03-14 | POTTI RAM Director | Conversion · Series E Convertible Preferred Stock | −187.5 | $1,000.00 | $188K | 1,625 |
| 2012-03-14 | EPIC PHARMA LLC 10% owner | Conversion | +7,621,951 | 63,443,669 | ||
| 2012-03-14 | EPIC PHARMA LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −187.5 | $1,000.00 | $188K | 1,625 |
| 2012-03-14 | EPIC INVESTMENTS, LLC 10% owner | Conversion | +7,621,951 | 63,443,669 | ||
| 2012-03-14 | EPIC INVESTMENTS, LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −187.5 | $1,000.00 | $188K | 1,625 |
| 2012-02-21 | POTTI RAM Director | Conversion | +52,845,528 | 55,821,718 | ||
| 2012-02-21 | POTTI RAM Director | Conversion · Series E Convertible Preferred Stock | −1,300 | $1,000.00 | $1.3M | 1,812.5 |
| 2012-02-21 | NARINE JEENARINE Director | Conversion | +52,845,528 | 56,229,667 | ||
| 2012-02-21 | NARINE JEENARINE Director | Conversion · Series E Convertible Preferred Stock | −1,300 | $1,000.00 | $1.3M | 1,812.5 |
| 2012-02-21 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion | +52,845,528 | 56,229,667 | ||
| 2012-02-21 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion · Series E Convertible Preferred Stock | −1,300 | $1,000.00 | $1.3M | 1,812.5 |
| 2012-02-21 | EPIC PHARMA LLC 10% owner | Conversion | +52,845,528 | 55,821,718 | ||
| 2012-02-21 | EPIC PHARMA LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −1,300 | $1,000.00 | $1.3M | 1,812.5 |
| 2012-02-21 | EPIC INVESTMENTS, LLC 10% owner | Conversion | +52,845,528 | 55,821,718 |
Page 25 of 28 · 542 trades